Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorOchoa-Guzman, A.
dc.contributor.authorChiquete, E.
dc.contributor.authorCantu-Brito, C.
dc.contributor.authorArauz, A.
dc.contributor.authorMurillo-Bonilla, L.
dc.contributor.authorVillarreal-Careaga, J.
dc.contributor.authorRuiz-Sandoval, J.L.
dc.description.abstractIntroduction: Little is known about the frequency and clinical outcome of cases with lupus-associated acute cerebrovascular disease in Mexico. Objective: To describe the prevalence and short-term outcome of lupus erythematosus in patients with the major forms of acute cerebrovascular disease in the Mexican multicenter registry RENAMEVASC. Methods: A total of 2000 patients were studied in the RENAMEVASC registry in 25 hospitals from 14 states of Mexico: 100 (5%) with transient ischemic attack (TIA), 992 (49.6%) with acute cerebral infarction (ACI), 580 (29%) with intracerebral hemorrhage (ICH), 269 (13.5%) with subarachnoid hemorrhage (SAH), and 59 (3%) with cerebral venous thrombosis (CVT). Results: In all, the prevalence of lupus erythematosus was 1.3% (95% confidence interval: 0.8-1.9%), significantly higher among cases with CVT (3.4%), than in SAH patients (0.4%, p = 0.03), but not higher than ICH (0.9%, p = 0.07), ICT (2%, p = 0.59) or ACI (1.6%, p = 0.31) cases. Compared with patients without lupus, those with this condition were significantly younger, with a high proportion of the female gender and antiphospholipid syndrome (in all, p < 0.05). Shortterm outcome of lupus patients was, in general, favorable, with an acute mortality not significantly different from patients without lupus (7.6 vs. 20.7%, respectively; p = 0.10), but with a lower proportion of cases with a modified Rankin score > 3 at dischrage (modified Rankin scale > 3, 11.5% vs. 49.4%, respectively; p < 0.001) and at 30-day follow-up (11.5 vs. 43%, respectively; p = 0.001). Conclusion: In Mexico, the frequency of lupus erythematosus in patients with acute cerebrovascular disease is < 2% and with shortterm mortality < 10%. � Copyright Indice Mexicano de Revistas Biom�dicas Latinoamericanas 1998 - 2011.
dc.titleLupus erythematosus in a multicenter hospital-based registry on acute cerebrovascular disease in Mexico: The RENAMEVASC study [Lupus eritematoso generalizado en un registro hospitalario multic�ntrico de enfermedad cerebrovascular aguda en M�xico: Estudio RENAMEVASC]
dc.relation.ispartofjournalRevista Mexicana de Neurociencia
dc.subject.keywordCerebral infarction; Lupus; Mexico; Outcome; Stroke
dc.contributor.affiliationOchoa-Guzm�n, A., Servicio de Neurolog�a, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; Chiquete, E., Servicio de Medicina Interna, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico; Cant�-Brito, C., Servicio de Neurolog�a, Cl�nica de Enfermedad Cerebrovascular, Instituto Nacional de Ciencias M�dicas Y de la Nutrici�n Salvador Zubir�n, Ciudad de M�xico, D.F., Mexico; Arauz, A., Cl�nica de Enfermedad Cerebrovascular, Instituto Nacional de Neurolog�a Y Neurocirug�a, Ciudad de M�xico, D.F., Mexico; Murillo-Bonilla, L., Facultad de Medicina, Universidad Aut�noma de Guadalajara, Guadalajara, Jalisco, Mexico; Villarreal-Careaga, J., Departamento de Neurolog�a, Hospital General de Culiac�n, Culiac�n, Sinaloa, Mexico; Ruiz-Sandoval, J.L., Servicio de Neurolog�a, Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco, Mexico, Departamento de Neurociencias, Centro Universitario de Ciencias de la Salud, Universidad de Guadalajara, Guadalajara, Jalisco, Mexico
Appears in Collections:Producción científica UdeG

Files in This Item:
There are no files associated with this item.

Items in RIUdeG are protected by copyright, with all rights reserved, unless otherwise indicated.